查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1598812

疫苗輸送設備市場：依性質、產品類型分類 - 2025-2030 年全球預測

Vaccine Delivery Devices Market by Nature (Needle Based, Needle-Less), Product Type (Jet Injectors, Microneedles, Syringes) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年疫苗輸送設備市場規模為69.3億美元，預計2024年將達到76.2億美元，複合年成長率為10.39%，到2030年將達到138.5億美元。

疫苗輸送設備市場的範圍和定義包括疫苗接種所必需的設備和技術，例如注射器、噴射注射器和微針貼片。疫苗開發的快速進步和對全球免疫計劃的重視推動了對這些設備的需求。疫苗輸送設備對於確保疫苗的有效管理、最大限度地減少浪費和提高患者的依從性至關重要。它們的應用範圍很廣，延伸到醫院、診所，甚至居家醫療機構，越來越依賴自我管理方法。最終用戶主要是醫療保健提供者、政府機構和預防醫學領域的個人。

主要市場統計
基準年[2023] 69.3億美元
預測年份 [2024] 76.2億美元
預測年份 [2030] 138.5億美元
複合年成長率（%） 10.39%

市場的關鍵成長要素包括無針給藥系統等技術進步、疫苗接種率上升以及對流行病預防的日益關注。最新的潛在商機在於數位醫療解決方案的整合，可以提高追蹤和管理的效率。由於醫療基礎設施的改善和政府措施不斷增多，新興市場具有巨大的成長潛力。然而，嚴格的法律規範、與創新輸送設備相關的高成本以及疫苗接種猶豫等挑戰可能會阻礙市場成長。

創新和研究的最佳方向是開發具有成本效益、方便且無痛的給藥方法，例如皮膚貼片和可攝入裝置，這些方法可以改變疫苗接種模式。由於市場充滿活力和競爭，企業應注重夥伴關係和協作，以促進創新和市場滲透。利用物聯網和人工智慧加強研發，準確追蹤和監控疫苗管理也可以為市場提供顯著優勢。總體而言，市場面臨與監管障礙和成本相關的挑戰，但對無痛、自我管理疫苗和數位醫療保健整合的努力為馬蘇提供了肥沃的土壤。

市場動態：揭示快速發展的疫苗傳輸設備市場的關鍵市場洞察

供需的動態交互作用正在改變疫苗輸送設備市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 慢性病和手術的增加
    • 增加免疫計劃、擴大疫苗接種舉措和宣傳活動
    • 政府策略投資新疫苗研發
  • 市場限制因素
    • 缺乏適當的基礎設施和高成本
  • 市場機會
    • 採用新的疫苗傳輸技術，包括無針技術
    • 開發安全疫苗輸送新設備
  • 市場挑戰
    • 血液感染疾病的感染風險與傳播

波特的五力：駕馭疫苗傳遞設備市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解疫苗輸送設備市場的外部影響

外部宏觀環境因素在塑造疫苗傳輸設備市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助企業預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解疫苗輸送設備市場的競爭格局

疫苗輸送設備市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣疫苗傳輸設備市場供應商的績效評估

FPNV定位矩陣是評估疫苗傳輸設備市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了疫苗輸送設備市場的成功之路

對於旨在加強在全球市場的影響力的公司來說，對疫苗輸送設備市場的策略分析至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 慢性病和手術的增加
      • 增加免疫規劃、擴大疫苗接種工作和宣傳活動
      • 政府對新疫苗研發的戰略投資優勢
    • 抑制因素
      • 缺乏適當的基礎設施和高成本
    • 機會
      • 採用新的疫苗接種技術，例如無針技術
      • 開發安全疫苗接種的新設備
    • 任務
      • 血液傳染感染疾病的感染及傳播風險
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章疫苗傳輸設備市場的本質

  • 針座
  • 沒有針

第7章疫苗輸送設備市場：依產品類型

  • 噴射注射器
  • 微型針
  • 注射器

第8章美洲疫苗傳輸設備市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太疫苗傳輸設備市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章歐洲、中東和非洲疫苗傳輸設備市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • 3M Company
  • Antares Pharma, Inc. by Halozyme, Inc.
  • Becton Dickinson & Company
  • Corium, Inc.
  • Gerresheimer AG
  • Inovio Pharmaceuticals, Inc.
  • Johnson & Johnson Services, Inc.
  • Medical International Technologies（MIT Canada）Inc.
  • Medline Industries, LP
  • PharmaJet, Inc.
  • Recipharm AB
  • Schott AG
  • Smith & Nephew PLC
  • Terumo Corporation
  • Viatris Inc.
Product Code: MRR-02026C4C8C99

The Vaccine Delivery Devices Market was valued at USD 6.93 billion in 2023, expected to reach USD 7.62 billion in 2024, and is projected to grow at a CAGR of 10.39%, to USD 13.85 billion by 2030.

The scope and definition of the vaccine delivery devices market encompass a range of instruments and technologies essential for the administration of vaccines, including syringes, jet injectors, and microneedle patches. The necessity for these devices is driven by the rapid advancements in vaccine development and the global emphasis on immunization programs. Vaccine delivery devices are crucial in ensuring the effective administration of vaccines, minimizing wastage, and enhancing patient compliance. Their applications are broad, spanning hospitals, clinics, and even at-home healthcare settings, with an increasing reliance on self-administration methods. End-users primarily include healthcare providers, governmental agencies, and individuals in areas of preventive healthcare.

KEY MARKET STATISTICS
Base Year [2023] USD 6.93 billion
Estimated Year [2024] USD 7.62 billion
Forecast Year [2030] USD 13.85 billion
CAGR (%) 10.39%

Key growth factors in the market include technological advancements like needle-free drug delivery systems, rising vaccination coverage, and an increased focus on pandemic preparedness. Latest potential opportunities lie in the integration of digital healthcare solutions which can enhance tracking and administration efficiency. Emerging markets offer significant growth possibilities due to improved healthcare infrastructure and increasing government initiatives to boost immunization rates. However, challenges such as stringent regulatory frameworks, high costs associated with innovative delivery devices, and vaccine hesitancy can impede market growth.

Innovation and research are best directed towards developing cost-effective, convenient, and painless delivery methods, such as skin patches or ingestible devices, which could revolutionize the vaccination landscape. As the market is highly dynamic and competitive, businesses should focus on partnerships and collaborations to foster innovation and market penetration. Enhanced R&D efforts utilizing IoT and AI for precise tracking and monitoring of vaccine administration can also present significant market advantages. Overall, while the market faces challenges related to regulatory hurdles and cost, the push towards painless, self-administration vaccines, coupled with digital healthcare integration, provides a fertile ground for growth and innovation.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Vaccine Delivery Devices Market

The Vaccine Delivery Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing chronic diseases and number of surgeries
    • Rising immunization programs, growing vaccination initiatives & campaigns
    • Favorable government strategic investment for the development of novel vaccines
  • Market Restraints
    • Lack of proper infrastructure for storage and high costs
  • Market Opportunities
    • Adoption of novel vaccine delivery technologies such as needle-free technologies
    • Developments of new devices for safe vaccine delivery
  • Market Challenges
    • Risk of infections and transmission of blood-borne infections

Porter's Five Forces: A Strategic Tool for Navigating the Vaccine Delivery Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Vaccine Delivery Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Vaccine Delivery Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Vaccine Delivery Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Vaccine Delivery Devices Market

A detailed market share analysis in the Vaccine Delivery Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Vaccine Delivery Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Vaccine Delivery Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Vaccine Delivery Devices Market

A strategic analysis of the Vaccine Delivery Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Vaccine Delivery Devices Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Antares Pharma, Inc. by Halozyme, Inc., Becton Dickinson & Company, Corium, Inc., Gerresheimer AG, Inovio Pharmaceuticals, Inc., Johnson & Johnson Services, Inc., Medical International Technologies (MIT Canada) Inc., Medline Industries, LP, PharmaJet, Inc., Recipharm AB, Schott AG, Smith & Nephew PLC, Terumo Corporation, and Viatris Inc..

Market Segmentation & Coverage

This research report categorizes the Vaccine Delivery Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Nature, market is studied across Needle Based and Needle-Less.
  • Based on Product Type, market is studied across Jet Injectors, Microneedles, and Syringes.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing chronic diseases and number of surgeries
      • 5.1.1.2. Rising immunization programs, growing vaccination initiatives & campaigns
      • 5.1.1.3. Favorable government strategic investment for the development of novel vaccines
    • 5.1.2. Restraints
      • 5.1.2.1. Lack of proper infrastructure for storage and high costs
    • 5.1.3. Opportunities
      • 5.1.3.1. Adoption of novel vaccine delivery technologies such as needle-free technologies
      • 5.1.3.2. Developments of new devices for safe vaccine delivery
    • 5.1.4. Challenges
      • 5.1.4.1. Risk of infections and transmission of blood-borne infections
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Vaccine Delivery Devices Market, by Nature

  • 6.1. Introduction
  • 6.2. Needle Based
  • 6.3. Needle-Less

7. Vaccine Delivery Devices Market, by Product Type

  • 7.1. Introduction
  • 7.2. Jet Injectors
  • 7.3. Microneedles
  • 7.4. Syringes

8. Americas Vaccine Delivery Devices Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Vaccine Delivery Devices Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Vaccine Delivery Devices Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 3M Company
  • 2. Antares Pharma, Inc. by Halozyme, Inc.
  • 3. Becton Dickinson & Company
  • 4. Corium, Inc.
  • 5. Gerresheimer AG
  • 6. Inovio Pharmaceuticals, Inc.
  • 7. Johnson & Johnson Services, Inc.
  • 8. Medical International Technologies (MIT Canada) Inc.
  • 9. Medline Industries, LP
  • 10. PharmaJet, Inc.
  • 11. Recipharm AB
  • 12. Schott AG
  • 13. Smith & Nephew PLC
  • 14. Terumo Corporation
  • 15. Viatris Inc.

LIST OF FIGURES

  • FIGURE 1. VACCINE DELIVERY DEVICES MARKET RESEARCH PROCESS
  • FIGURE 2. VACCINE DELIVERY DEVICES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL VACCINE DELIVERY DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL VACCINE DELIVERY DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL VACCINE DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL VACCINE DELIVERY DEVICES MARKET SIZE, BY NATURE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL VACCINE DELIVERY DEVICES MARKET SIZE, BY NATURE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL VACCINE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL VACCINE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS VACCINE DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS VACCINE DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES VACCINE DELIVERY DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES VACCINE DELIVERY DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC VACCINE DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC VACCINE DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA VACCINE DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA VACCINE DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. VACCINE DELIVERY DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. VACCINE DELIVERY DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. VACCINE DELIVERY DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL VACCINE DELIVERY DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL VACCINE DELIVERY DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL VACCINE DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. VACCINE DELIVERY DEVICES MARKET DYNAMICS
  • TABLE 7. GLOBAL VACCINE DELIVERY DEVICES MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL VACCINE DELIVERY DEVICES MARKET SIZE, BY NEEDLE BASED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL VACCINE DELIVERY DEVICES MARKET SIZE, BY NEEDLE-LESS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL VACCINE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL VACCINE DELIVERY DEVICES MARKET SIZE, BY JET INJECTORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL VACCINE DELIVERY DEVICES MARKET SIZE, BY MICRONEEDLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL VACCINE DELIVERY DEVICES MARKET SIZE, BY SYRINGES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. AMERICAS VACCINE DELIVERY DEVICES MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS VACCINE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS VACCINE DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 17. ARGENTINA VACCINE DELIVERY DEVICES MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
  • TABLE 18. ARGENTINA VACCINE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 19. BRAZIL VACCINE DELIVERY DEVICES MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
  • TABLE 20. BRAZIL VACCINE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 21. CANADA VACCINE DELIVERY DEVICES MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
  • TABLE 22. CANADA VACCINE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. MEXICO VACCINE DELIVERY DEVICES MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
  • TABLE 24. MEXICO VACCINE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. UNITED STATES VACCINE DELIVERY DEVICES MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES VACCINE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES VACCINE DELIVERY DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 28. ASIA-PACIFIC VACCINE DELIVERY DEVICES MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC VACCINE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC VACCINE DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 31. AUSTRALIA VACCINE DELIVERY DEVICES MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
  • TABLE 32. AUSTRALIA VACCINE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. CHINA VACCINE DELIVERY DEVICES MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
  • TABLE 34. CHINA VACCINE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. INDIA VACCINE DELIVERY DEVICES MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
  • TABLE 36. INDIA VACCINE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. INDONESIA VACCINE DELIVERY DEVICES MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
  • TABLE 38. INDONESIA VACCINE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. JAPAN VACCINE DELIVERY DEVICES MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
  • TABLE 40. JAPAN VACCINE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. MALAYSIA VACCINE DELIVERY DEVICES MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
  • TABLE 42. MALAYSIA VACCINE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. PHILIPPINES VACCINE DELIVERY DEVICES MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
  • TABLE 44. PHILIPPINES VACCINE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. SINGAPORE VACCINE DELIVERY DEVICES MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
  • TABLE 46. SINGAPORE VACCINE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. SOUTH KOREA VACCINE DELIVERY DEVICES MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
  • TABLE 48. SOUTH KOREA VACCINE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. TAIWAN VACCINE DELIVERY DEVICES MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
  • TABLE 50. TAIWAN VACCINE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. THAILAND VACCINE DELIVERY DEVICES MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
  • TABLE 52. THAILAND VACCINE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. VIETNAM VACCINE DELIVERY DEVICES MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
  • TABLE 54. VIETNAM VACCINE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. EUROPE, MIDDLE EAST & AFRICA VACCINE DELIVERY DEVICES MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA VACCINE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA VACCINE DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 58. DENMARK VACCINE DELIVERY DEVICES MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
  • TABLE 59. DENMARK VACCINE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. EGYPT VACCINE DELIVERY DEVICES MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
  • TABLE 61. EGYPT VACCINE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. FINLAND VACCINE DELIVERY DEVICES MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
  • TABLE 63. FINLAND VACCINE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. FRANCE VACCINE DELIVERY DEVICES MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
  • TABLE 65. FRANCE VACCINE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. GERMANY VACCINE DELIVERY DEVICES MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
  • TABLE 67. GERMANY VACCINE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. ISRAEL VACCINE DELIVERY DEVICES MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
  • TABLE 69. ISRAEL VACCINE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. ITALY VACCINE DELIVERY DEVICES MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
  • TABLE 71. ITALY VACCINE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. NETHERLANDS VACCINE DELIVERY DEVICES MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
  • TABLE 73. NETHERLANDS VACCINE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. NIGERIA VACCINE DELIVERY DEVICES MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
  • TABLE 75. NIGERIA VACCINE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. NORWAY VACCINE DELIVERY DEVICES MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
  • TABLE 77. NORWAY VACCINE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. POLAND VACCINE DELIVERY DEVICES MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
  • TABLE 79. POLAND VACCINE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. QATAR VACCINE DELIVERY DEVICES MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
  • TABLE 81. QATAR VACCINE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. RUSSIA VACCINE DELIVERY DEVICES MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
  • TABLE 83. RUSSIA VACCINE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. SAUDI ARABIA VACCINE DELIVERY DEVICES MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
  • TABLE 85. SAUDI ARABIA VACCINE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH AFRICA VACCINE DELIVERY DEVICES MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH AFRICA VACCINE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. SPAIN VACCINE DELIVERY DEVICES MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
  • TABLE 89. SPAIN VACCINE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. SWEDEN VACCINE DELIVERY DEVICES MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
  • TABLE 91. SWEDEN VACCINE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. SWITZERLAND VACCINE DELIVERY DEVICES MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
  • TABLE 93. SWITZERLAND VACCINE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. TURKEY VACCINE DELIVERY DEVICES MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
  • TABLE 95. TURKEY VACCINE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED ARAB EMIRATES VACCINE DELIVERY DEVICES MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED ARAB EMIRATES VACCINE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED KINGDOM VACCINE DELIVERY DEVICES MARKET SIZE, BY NATURE, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED KINGDOM VACCINE DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. VACCINE DELIVERY DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 101. VACCINE DELIVERY DEVICES MARKET, FPNV POSITIONING MATRIX, 2023